Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The 2024 annual call for changes in the national screening programs is now open in the UK

On July 1, 2024, the annual call for proposals to the UK National Screening Committee (UK NSC) was launched. The deadline for applications is September 30, 2024. 

During the annual call period, individuals or organizations can submit proposals for:

  • New screening topics;
  • Requesting an early update for topics that the UK NSC has considered within the past three years;
  • Modifications to, or the ceasing of, existing screening programs.

Proposals can cover population screening, targeted screening, or stratified screening topics.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.